A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Clinical trial NCT04450394 · COMPLETED

Trial details

NCT number: NCT04450394
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2020-07-01
Primary completion: 2021-10-08
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.